⌘K
t
GSK PLC applied on 11 December 2025 to the Financial Conduct Authority and the London Stock Exchange for a block listing of 250,000 Ordinary Shares of 31¼p each. These shares are designated for issuance under the GlaxoSmithKline plc Share Save Plan 2022. Admission to the Official List is expected to be effective on 12 December 2025, with the shares ranking pari passu with existing Ordinary Shares when issued.
| Date | 11 Dec 2025 |
| Time | 09:00:00 |
| Category | Capital structure |
| ID | 0709L |
Issued: 11 December 2025, London UK
Block Listing Application
Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 250,000 Ordinary Shares of 31¼p each ('Shares') to be admitted to the Official List.
The Shares are being reserved under a block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2022.
When issued, the Shares will rank pari passu with the existing Ordinary Shares of 31¼p each.
Admission is expected to be effective on 12 December 2025.
V A Whyte
Company Secretary
11 December 2025
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
Registered in England & Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG